These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
384 related items for PubMed ID: 32425522
1. Dual Receptor-Targeted and Redox-Sensitive Polymeric Micelles Self-Assembled from a Folic Acid-Hyaluronic Acid-SS-Vitamin E Succinate Polymer for Precise Cancer Therapy. Yang Y, Li Y, Chen K, Zhang L, Qiao S, Tan G, Chen F, Pan W. Int J Nanomedicine; 2020; 15():2885-2902. PubMed ID: 32425522 [Abstract] [Full Text] [Related]
2. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment. Song Y, Cai H, Yin T, Huo M, Ma P, Zhou J, Lai W. Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586 [Abstract] [Full Text] [Related]
3. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. Liu Y, Sun J, Cao W, Yang J, Lian H, Li X, Sun Y, Wang Y, Wang S, He Z. Int J Pharm; 2011 Dec 12; 421(1):160-9. PubMed ID: 21945183 [Abstract] [Full Text] [Related]
4. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid. Yin S, Huai J, Chen X, Yang Y, Zhang X, Gan Y, Wang G, Gu X, Li J. Acta Biomater; 2015 Oct 12; 26():274-85. PubMed ID: 26300335 [Abstract] [Full Text] [Related]
5. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy. Hou L, Tian C, Chen D, Yuan Y, Yan Y, Huang Q, Zhang H, Zhang Z. Eur J Pharm Sci; 2019 Dec 01; 140():105071. PubMed ID: 31525433 [Abstract] [Full Text] [Related]
6. Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel. Li J, Yin T, Wang L, Yin L, Zhou J, Huo M. Int J Pharm; 2015 Apr 10; 483(1-2):38-48. PubMed ID: 25655715 [Abstract] [Full Text] [Related]
7. Enhanced cytotoxicity of a redox-sensitive hyaluronic acid-based nanomedicine toward different oncocytes via various internalization mechanisms. Du Y, Wang S, Zhang T, He D, Tu J, Shen Y. Drug Deliv; 2020 Dec 10; 27(1):128-136. PubMed ID: 31894722 [Abstract] [Full Text] [Related]
8. pH-sensitive and folic acid-targeted MPEG-PHIS/FA-PEG-VE mixed micelles for the delivery of PTX-VE and their antitumor activity. Di Y, Li T, Zhu Z, Chen F, Jia L, Liu W, Gai X, Wang Y, Pan W, Yang X. Int J Nanomedicine; 2017 Dec 10; 12():5863-5877. PubMed ID: 28860753 [Abstract] [Full Text] [Related]
14. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel. Yang X, Cai X, Yu A, Xi Y, Zhai G. J Colloid Interface Sci; 2017 Jun 15; 496():311-326. PubMed ID: 28237749 [Abstract] [Full Text] [Related]
15. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Li J, Huo M, Wang J, Zhou J, Mohammad JM, Zhang Y, Zhu Q, Waddad AY, Zhang Q. Biomaterials; 2012 Mar 15; 33(7):2310-20. PubMed ID: 22166223 [Abstract] [Full Text] [Related]
16. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle. Rezazadeh M, Emami J, Hasanzadeh F, Sadeghi H, Minaiyan M, Mostafavi A, Rostami M, Lavasanifar A. Drug Deliv; 2016 Jun 15; 23(5):1707-17. PubMed ID: 25188785 [Abstract] [Full Text] [Related]
20. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery. Yang Y, Zhao Y, Lan J, Kang Y, Zhang T, Ding Y, Zhang X, Lu L. Int J Nanomedicine; 2018 Jun 15; 13():4361-4378. PubMed ID: 30100720 [Abstract] [Full Text] [Related] Page: [Next] [New Search]